Insight Genetics raises $3M for breast, lung cancer diagnostics
Tennessee startup Insight Genetics, a precision medicine company transitioning its diagnostic assays so they work in liquid biopsy, just raised $3 million for its tests that detect breast, thyroid and lung cancers.